Enovis Surgical
DJO Global develops, manufactures, and distributes a wide array of medical devices focused on rehabilitation, pain management, and physical therapy. The company operates through four segments: Bracing and Vascular, Recovery Sciences, Surgical Implant, and International. Its product offerings include rigid knee braces, orthopedic soft goods, cold therapy products, vascular therapy systems, therapeutic shoes, and compression therapy products, marketed under various brands such as DonJoy, ProCare, and Aircast. Additionally, DJO Global provides bone growth stimulators, clinical electrotherapy devices, and other physical therapy equipment tailored for use by healthcare professionals, including orthopedic specialists, spine surgeons, and physical therapists. The company also has a surgical division that offers reconstructive joint products for the hip, knee, and shoulder. With a commitment to addressing the continuum of patient care, DJO Global’s devices facilitate injury prevention and rehabilitation, enabling individuals to regain their natural motion. The company distributes its products through direct sales representatives and a network of dealers and distributors across various global markets. Founded in 1978 and based in Vista, California, DJO Global is a subsidiary of Colfax Corporation.
Top Stages
6 past transactions
Novastep
Acquisition in 2023
Novastep is a global medical device company based in Englewood Cliffs, New Jersey, specializing in the design, development, and commercialization of products aimed at treating conditions affecting the bones, joints, and soft tissues of the foot and ankle. The company is dedicated to delivering innovative solutions and medical education to enhance the practices of surgeons and improve patient outcomes. By collaborating closely with surgeon inventors and customers, Novastep identifies and addresses challenges within clinical settings. This commitment drives the continuous development of new and enhanced devices specifically tailored for the foot and ankle market.
Mathys
Acquisition in 2021
Mathys develops, produces and distributes products for artificial joint replacement, synthetic bone graft substitute and sports medicine.
MedShape
Acquisition in 2021
MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.
Trilliant Surgical
Acquisition in 2021
Trilliant Surgical, LLC, founded in 2007 and based in Houston, Texas, specializes in the creation and manufacture of medical devices for small bone orthopedic correction. The company provides a comprehensive range of small bone implants designed for elective and trauma procedures, catering specifically to the needs of foot and ankle surgeons. Its product offerings include cannulated screw fixation systems, foot and ankle plates, bunion plating, hammer toe correction devices, subtalar implants, staple fixation systems, hemi toe implants, and biologics for various foot and ankle procedures. Trilliant Surgical is dedicated to innovation in podiatric implants and surgical instrumentation, emphasizing high-quality, cost-effective, and user-friendly products that enhance patient outcomes and support the practices of podiatrists and orthopedic surgeons.
LiteCure
Acquisition in 2020
LiteCure, LLC is a medical device manufacturing company based in New Castle, Delaware, specializing in advanced laser technology for both human and veterinary healthcare. Incorporated in 2006, LiteCure designs and produces a range of medical devices, including deep tissue therapy lasers aimed at pain management for patients and companion laser therapies for pet owners. The company operates through its divisions, LiteCure Medical and Companion Therapy, and is recognized for its commitment to quality, with products that are FDA cleared and manufactured under strict quality control systems certified to ISO-9001 and ISO-13485 standards. LiteCure leverages expertise in physics, laser science, and engineering to deliver innovative solutions that enhance therapeutic outcomes in healthcare. As of December 2020, LiteCure is a subsidiary of DJO Global, Inc.
Iomed
Acquisition in 2007
IOMED, Inc.develops, manufactures and commercializes controllable drug delivery systems using iontophoretic technology. Iontophoresis is a non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs into and through the skin using a low level electrical current. The Company's proprietary iontophoretic drug delivery systems allow rapid onset and cessation of therapeutic action, as well as programmable dose control. The systems enable caregivers and patients to control the onset of drug effectiveness and maintain, reduce or cease drug administration once a desired therapeutic effect is observed. The programming feature also enables caregivers to customize dosing patterns to meet each patient's specific needs. The Company is developing systems designed to enable patient monitoring and control. The flexibility of the Company's proprietary systems provides therapeutic control not possible with many alternative drug delivery methods, including oral tablets and capsules, injections, inhalants and passive transdermal patches. The Company's systems may also increase bioavailability, safety and patient comfort.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.